The ryanodine receptor type 1 (RyR1) is a homotetrameric Ca 2؉ release channel located in the sarcoplasmic reticulum of skeletal muscle where it plays a role in the initiation of skeletal muscle contraction. A soluble, 6؋-histidine affinity-tagged cytosolic fragment of RyR1 (amino acids 1-4243) was expressed in HEK-293 cells, and metal affinity chromatography under native conditions was used to purify the peptide together with interacting proteins. When analyzed by gel-free liquid chromatography mass spectrometry (LC-MS), 703 proteins were identified under all conditions. This group of proteins was filtered to identify putative RyR interacting proteins by removing those proteins found in only 1 RyR purification and proteins for which average spectral counts were enriched by less than 4-fold over control values. This resulted in 49 potential RyR1 interacting proteins, and 4 were selected for additional interaction studies: calcium homeostasis endoplasmic reticulum protein (CHERP), endoplasmic reticulum-Golgi intermediate compartment 53-kDa protein (LMAN1), T-complex protein, and phosphorylase kinase. Western blotting showed that only CHERP co-purified with affinity-tagged RyR1 and was eluted with imidazole. Immunofluorescence showed that endogenous CHERP co-localizes with endogenous RyR1 in the sarcoplasmic reticulum of rat soleus muscle. A combination of overexpression of RyR1 in HEK-293 cells with siRNA-mediated suppression of CHERP showed that CHERP affects Ca 2؉ release from the ER via RyR1. Thus, we propose that CHERP is an RyR1 interacting protein that may be involved in the regulation of excitation-contraction coupling.In skeletal muscle excitation-contraction (EC) 4 coupling is prominent among the processes controlled by Ca 2ϩ (1). The sequence of EC coupling events begins with the depolarization of sarcolemmal and transverse tubular membranes that triggers a conformational change in the dihydropyridine receptor (DHPR). Protein-protein interactions between the DHPR and the ryanodine receptor type 1 (RyR1) lead to the activation of the Ca 2ϩ release channel function of RyR1, the release of Ca 2ϩ from the SR via RyR1, and the generation of skeletal muscle contraction. Subsequently, relaxation is initiated by re-uptake of intracellular Ca 2ϩ through the action of the sarco/endoplasmic reticulum Ca 2ϩ -ATPase type 1 (SERCA1a). The correct functioning of the contraction/relaxation cycle relies on a precise balance between Ca 2ϩ release and re-uptake. Disruptions in this balance, such as those that result from mutations in the proteins involved in the Ca 2ϩ uptake and release processes, lead to muscle diseases, including Brody disease, malignant hyperthermia, central core disease, and cardiomyopathies (2-5).RyR1 has numerous interacting protein partners; that is, both integral membrane proteins such as DHPR, junction, and triadin (6) and soluble proteins such as FK506-binding proteins, calmodulin, protein kinases, and phosphatases (6 -9). These protein interactors are proposed to comprise an RyR1 Ca 2ϩ release ...